Managed Care Considerations in HPV: Overcoming Barriers for
Improved Patient Outcomes

A continuing medical education activity sponsored by NAMCP and AAMCN

 Managed Care Considerations in HPV: Overcoming Barriers for Improved Patient Outcomes is a 3-part
webcast series that will explore the latest clinical advances and recent data regarding HPV vaccination,
strategies for overcoming barriers, and what managed care needs to know around HPV and vaccination.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in all 3 or in order.

These are archives of live webinars held between April 3 to April 12, 2019.
If you participated in any of the live webinars, you are not eligible to claim credit from the archive of that webinar.

Each session has its own specific valid dates

This series is supported by an educational grant froM

Merck Sharp & Dohme Corp.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

 Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.  

 To print or save your certificate, you will need to click on the “download” button and either print or save.

These presentations require Adobe Flash Player.  You can download it here.


Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various types of cancer. An estimated 79 million people in the United States are infected with some type of HPV, and approximately 50% of new infections occur in individuals before the age of 24. Despite the availability of safe and effective vaccines, HPV vaccination coverage remains low. There are various reasons why the vaccination rates are low, including patients’ and/or parents' lack of knowledge about HPV and their discomfort with talking to health care providers about sexual activity, affordability, among other reasons.

Part 1
Recent Updates on Vaccinations in HPV: Key Considerations for Improved Patient Outcomes

  • Review the prevalence of HPV infection, the types of cancers it causes and the impact of HPV vaccination in theUnitedStates

  • Analyze prevention strategies that reflect recent clinical advances in HPV vaccination and clinical practice guidelines

  • Outline the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention recommendations for HPV vaccination

  • Assess the latest evidence regarding the increasing burden of HPV-related, non-cervical cancers and implications for at-risk patients, especially males

  • Examine the evolving role of HPV vaccinations in adults
    Physician, Nursing and CMCN credits valid to May 1, 2020

Part 2
Addressing the Challenges of HPV Vaccinations: Strategies for Overcoming Barriers

  • Identify perceived barriers by both healthcare providers and patients to HPV vaccination

  • Examine strategies to overcome barriers that impede successful completion of the HPV vaccination series

  • Evaluate the value of concise and consistent communication to educate patients/caregivers on the importance of competing the HPV vaccination series

  • Assess new strategies to educate and empower adolescents to become engaged in their own health as it relates to HPV vaccination
    , Nursing and CMCN credits valid to May 1, 2020

Part 3

What Does Managed Care Need to Know about Vaccinations in the Management of HPV?

  • Assess the latest clinical data regarding the impact of HPV vaccination on relevant clinical endpoints
  • Identify key economic challenges surrounding HPV immunization in adolescents and adults and the need for more optimal medical intervention to reduce healthcare costs
  • Apply methods to enable optimal cost management of vaccinations to be realized by multiple HPV stakeholders including managed care organizations
    , Nursing and CMCN credits valid to May 1, 2020